Journal: Cellular and Molecular Gastroenterology and Hepatology
Article Title: Nanoparticle-Mediated Delivery of 2-Deoxy-D-Glucose Induces Antitumor Immunity and Cytotoxicity in Liver Tumors in Mice
doi: 10.1016/j.jcmgh.2020.10.010
Figure Lengend Snippet: Effects of 2DG or 2DG-PLGA-NPs on ATP production, cytotoxicity, tumor vessel formation, and ROS production. ( A and B ) Total, glycolytic, and mitochondrial ATP production rates were measured in the Huh7 cells (3 × 10 4 cells/well) using a Seahorse XF24 Extracellular Flux Analyzer. The extracellular acidification rate and oxygen consumption rate (OCR) were analyzed after injection of 2DG (0, 1, 5, 10, and 50 mmol/L). Glycolytic and mitochondrial ATP production rates were determined based on the extracellular acidification rates and OCRs using an Agilent Seahorse XFp Real-Time ATP rate assay report generator. ∗ P < .05, ∗∗ P < .01, and ∗∗∗ P < .001. ( C ) Immunoblots showing results for p-AMPK, AMPK, p-mTOR, mTOR, p-S6, S6, p-Rb, Rb, spliced x-box binding protein 1 (XBP-1s), CCAAT/enhancer binding protein-homologous protein (CHOP), activating transcription factor 4 (ATF4), cyclin D1, proliferating cell nuclear antigen (PCNA), and vascular endothelial growth factor (VEGF)-A, performed using xenograft tumors in each nude mouse group (n = 3). Column a, 2DG (100 mg/kg); column b, 2DG (1000 mg/kg); column c, 2DG-PLGA-NP (80 mg/kg); and column d, 2DG-PLGA-NP (800 mg/kg). Administration frequency was daily for 2DG (intraperitoneal) and weekly for 2DG-PLGA-NPs (intravenous). The amount of phosphorylated protein was normalized to total protein. The amount of some proteins was normalized to that of β-actin. ∗ P < .05, ∗∗ P < .01, and ∗∗∗ P < .001. ( D ) Immunostained CD34-positive vessels and ( E ) dihydroethidium staining for detecting ROS production in the Huh7 cell xenograft tumors 21 days after the commencement of treatment in the 5 groups as indicated (n = 3 for each group) (original magnification: ×400). Administration frequency was daily for 2DG (intraperitoneal) and weekly for 2DG-PLGA-NPs (intravenous). National Institutes of Health image analysis software was used to quantify the mean percentage of the positively stained area of 5 randomly selected fields in the digital images of each tumor. ∗ P < .05, ∗∗ P < .01, and ∗∗∗ P < .001. Column 1, control; column 2, 2DG (100 mg/kg); column 3, 2DG (1000 mg/kg); column 4, 2DG-PLGA-NP (80 mg/kg); and column 5, 2DG-PLGA-NP (800 mg/kg). Cont, control; FCCP, carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone.
Article Snippet: The samples subsequently were incubated overnight at 4°C with the following antibodies: a rabbit anti–phospho-AMPKα (Thr172) monoclonal antibody (Cell Signaling Technology), a rabbit anti-AMPKα monoclonal antibody (Cell Signaling Technology), a rabbit anti–phospho-mTOR (Ser2448) monoclonal antibody (Cell Signaling Technology), a rabbit anti-mTOR monoclonal antibody (Cell Signaling Technology), a rabbit anti–phospho-S6 ribosomal protein (Ser235/236) monoclonal antibody (Cell Signaling Technology), a mouse anti-S6 ribosomal protein monoclonal antibody (Cell Signaling Technology), a rabbit anti–phospho-Rb (Ser780) polyclonal antibody (Cell Signaling Technology), a mouse anti-Rb monoclonal antibody (Cell Signaling Technology), a rabbit anti–spliced x-box binding protein 1 monoclonal antibody (Cell Signaling Technology), a mouse anti–CCAAT/enhancer binding protein-homologous protein monoclonal antibody (Cell Signaling Technology), a rabbit anti– activating transcription factor 4 monoclonal antibody (Cell Signaling Technology), a rabbit anti–cyclin D1 monoclonal antibody (Cell Signaling Technology), a mouse anti–proliferating cell nuclear antigen monoclonal antibody (Santa Cruz Biotechnology, Santa Cruz, CA), a rabbit anti–vascular endothelial growth factor polyclonal antibody (Abcam, Cambridge, UK), a rabbit anti–phospho-JAK1 monoclonal antibody (Cell Signaling Technology), a rabbit anti-JAK1 monoclonal antibody (Cell Signaling Technology), a rabbit anti–phospho-JAK2 monoclonal antibody (Cell Signaling Technology), a rabbit anti-JAK2 monoclonal antibody (Cell Signaling Technology), a rabbit anti–phospho-STAT1 (Tyr701) monoclonal antibody (Cell Signaling Technology), a rabbit anti-STAT1 monoclonal antibody (Cell Signaling Technology), a rabbit anti–phospho-EZH2 (Thr311) polyclonal antibody (Cell Signaling Technology), a rabbit anti-EZH2 monoclonal antibody (Cell Signaling Technology), and a rabbit anti–trimethyl-histone H3 (Lys27) polyclonal antibody (Sigma-Aldrich).
Techniques: Injection, Western Blot, Binding Assay, Staining, Software